Edition:
United States

Acasti Pharma Inc (ACST.OQ)

ACST.OQ on NASDAQ Stock Exchange Capital Market

1.51USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$1.51
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
75,332
52-wk High
$3.34
52-wk Low
$1.11

Revenue & Earnings Per Share

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Year Ending Feb-17 1 0.04 0.04 0.04 --
Year Ending Feb-18 1 0.00 0.00 0.00 0.04
Year Ending Feb-19 1 0.00 0.00 0.00 0.06
Earnings (per share)
Year Ending Feb-17 1 -0.74 -0.74 -0.74 --
Year Ending Feb-18 1 -0.77 -0.77 -0.77 -0.77
Year Ending Feb-19 1 -0.98 -0.98 -0.98 -0.71
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 31.96 35.37
P/E High - Last 5 Yrs. -- 40.69 45.18
P/E Low - Last 5 Yrs. -- 23.59 24.20
Beta -- 0.92 0.91
Price to Sales (TTM) -- 3.91 5.84
Price to Book (MRQ) -- 4.83 5.65
Price to Tangible Book (MRQ) -- 5.71 7.25
Price to Cash Flow (TTM) -- 22.91 24.30
% Owned Institutions -- 0.87 1.41

Dividends

  Company industry sector
Dividend Yield -- 1.57 1.50
Dividend Yield - 5 Year Avg -- 2.17 2.05
Dividend 5 Year Growth Rate -- 4.31 5.25
Payout Ratio(TTM) -- 47.35 46.04

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 6.32 6.82
Sales (TTM) vs TTM 1 Yr. Ago -- 5.16 5.63
Sales - 5 Yr. Growth Rate -- 10.00 10.25
EPS (MRQ) vs Qtr. 1 Yr. Ago -- 7.16 7.98
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 9.91 10.92
Capital Spending - 5 Yr. Growth Rate -- 15.15 15.16

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.49 2.55
Current Ratio (MRQ) -- 3.50 3.56
LT Debt to Equity (MRQ) -- 11.00 13.37
Total Debt to Equity (MRQ) -- 17.17 19.40
Interest Coverage (TTM) -- 50.11 44.77

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.23 54.89
Gross Margin - 5 Yr. Avg. -- 52.34 52.44
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- 18.38 15.52
Operating Margin (TTM) -- 14.75 6.76
Operating Margin - 5 Yr. Avg. -- 14.34 11.02
Pre-Tax Margin (TTM) -- 15.20 7.58
Pre-Tax Margin - 5 Yr. Avg. -- 14.65 11.42
Net Profit Margin (TTM) -- 11.38 3.81
Net Profit Margin - 5 Yr. Avg. -- 10.99 7.71
Effective Tax Rate (TTM) -- 24.35 24.25
Effective Tax Rate - 5 Yr. Avg. -- 23.46 24.06

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 945,714,200 852,152,758
Net Income/Employee (TTM) -- 110,550,430 99,529,045
Receivable Turnover (TTM) -- 5.91 6.14
Inventory Turnover (TTM) -- 2.73 3.55
Asset Turnover (TTM) -- 0.99 0.97

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- 11.87 11.32
Return on Assets - 5 Yr. Avg. -- 12.87 12.29
Return on Investment (TTM) -- 15.07 14.45
Return on Investment - 5 Yr. Avg. -- 16.83 16.09
Return on Equity (TTM) -- 16.58 16.05
Return on Equity - 5 Yr. Avg. -- 17.85 17.30
Note: Units in Millions of US Dollars

Performance for Acasti Pharma Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.